Harmony Biosciences Holdings, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of HRMY for the last quarter is 168.41 M USD, and it's 5.08% higher compared to the previous quarter. The net income of Q4 23 is 26.61 M USD.